Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy

Siu W. Lam, Nienke M. Nota, Agnes Jager, Monique M. E. M. Bos, Joan van den Bosch, Ankie M. T. van der Velden, Johanneke E. A. Portielje, Aafke H. Honkoop, Harm van Tinteren, Epie Boven

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1611-1620
JournalClinical Cancer Research
Volume22
Issue number7
DOIs
Publication statusPublished - 1 Apr 2016

Cite this